Abstract
BackgroundTreatment of some blood cancers with T cells that express a chimeric antigen receptor (CAR) against CD19 have shown remarkable results. In contrast, CAR-T cell efficacy against solid tumors has...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have